1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Oxford Square Capital reported results for the quarter ended June 30, 2026, and declared distributions of $0.035 per share for each of October, November and December 2026. Net investment income rose to about $5.1 million from about $4.1 million in the prior quarter, but net asset value per share fell to $1.29 from $1.32, and the company recorded about $36.0 million in net realized losses for the six months. Shareholders are weighing a sequential improvement in income against a lower net asset value and larger losses so far this year.
Net investment income was about $5.1 million, or $0.05 per share, for the quarter, compared with about $4.1 million, or $0.05 per share, for the first quarter of 2026.
Net asset value per share was $1.29 at June 30, 2026, down from $1.32 at March 31, 2026.
Net increase in net assets from operations was about $4.0 million for the quarter, but the six-month result was a decrease of about $21.5 million.
Declared monthly distributions of $0.035 per share, with payment dates of October 30, November 30 and December 31, 2026.
FTI Consulting reported record second-quarter 2026 revenue of $993.5 million, up 5.3% from $943.7 million a year earlier, but net income fell to $57.8 million from $71.7 million and diluted EPS fell to $1.99 from $2.13. The company lowered its full-year 2026 EPS guidance to $8.70-$9.30 from $8.90-$9.60 while reaffirming its revenue guidance, so shareholders face lower expected per-share earnings even as sales grow.
Q2 2026 revenue $993.5 million, up 5.3%; net income $57.8 million vs. $71.7 million in Q2 2025
Diluted EPS $1.99 vs. $2.13; Adjusted EPS $2.16 vs. $2.13, excluding $6.6 million of Extraordinary Litigation-Related Expenses
Full-year 2026 EPS guidance cut to $8.70-$9.30 from $8.90-$9.60; Adjusted EPS guidance $9.10-$9.70; revenue guidance reaffirmed at $3.940-$4.100 billion
Repurchased 2,591,133 shares for $390.9 million in Q2; about $344.0 million remained under the buyback program at June 30, 2026
Universal Logistics reported second-quarter 2026 results for the thirteen weeks ended July 4, 2026. Revenue fell to $379.3 million from $393.8 million, while GAAP earnings rose to $0.99 per share from $0.32, helped by a $45.3 million gain on a property sale; excluding that gain and certain charges, adjusted EPS was $0.16 versus $0.32 a year earlier. The board also declared a $0.105 per share quarterly dividend.
Operating revenues were $379.3 million, compared with $393.8 million in the second quarter of 2025.
GAAP income from operations was $45.1 million, including a $45.3 million gain on the sale of Kearny, New Jersey property and $12.3 million of legal charges.
Adjusted EPS was $0.16 versus $0.32; adjusted EBITDA was $49.2 million versus $56.2 million.
Intermodal segment revenue fell 36.0% to $44.1 million and posted an operating loss of $(10.4) million.
Amgen disclosed in an SEC 8-K filed July 31, 2026 that unauthorized actors accessed and exfiltrated some company data, including proprietary data and patient protected health information, from cloud environments hosted by third-party providers. The company determined on July 29, 2026 that the incident is material, but says it has not identified any impact on products, manufacturing, financial reporting systems, or its ability to meet patient needs, and does not expect a material effect on financial condition or results.
Unauthorized activity was identified in July 2026 in data stored in third-party-hosted cloud environments.
Company determined on July 29, 2026 that the incident is material, citing file volume and the sensitivity of the information.
Amgen believes the incident is not reasonably likely to have a material impact on its financial condition or results of operations.
Investigation is ongoing, and patient notifications will be made as required.
Franklin Resources reported third-quarter results for the period ended June 30, 2026, with operating revenues up 3% from the prior quarter and 14% from a year earlier. Net income fell 36% from the prior quarter to $171.5 million, though it rose 86% from the year-earlier quarter. The company also said it will change its corporate name to Franklin Templeton, Inc. effective August 17, 2026, with the stock continuing to trade under BEN.
Operating revenues were $2,358.4 million, up 3% from $2,294.9 million in the prior quarter and up 14% from $2,064.0 million a year earlier.
Net income attributable to the company was $171.5 million, or $0.31 per diluted share, compared with $268.2 million, or $0.49 per share, in the prior quarter.
Adjusted operating income of $508.9 million excludes a $100.0 million charge related to significant regulatory settlements.
The corporate name changes to Franklin Templeton, Inc. effective August 17, 2026; the NYSE ticker remains BEN.
IRADIMED reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, while net income fell 10% to $5.2 million and diluted EPS fell to $0.41 from $0.45. The company reaffirmed its full-year 2026 revenue and EPS guidance and declared a $0.20 per share quarterly dividend. Management said the first production ramp of the new 3870 IV pump met its plan, and the quarterly gross profit margin fell to 74% from 78%.
Q2 2026 revenue was $20.5 million, up $0.1 million from $20.4 million in Q2 2025.
Q2 2026 GAAP diluted EPS was $0.41 versus $0.45 a year earlier; non-GAAP diluted EPS was $0.46 versus $0.49.
Full-year 2026 guidance reaffirmed: revenue of $91.0 million to $96.0 million and GAAP diluted EPS of $1.90 to $2.05.
Q3 2026 guidance: revenue of $23.0 million to $24.5 million and GAAP diluted EPS of $0.49 to $0.54.
Colgate-Palmolive reported second-quarter 2026 net sales of $5,361 million, up 4.9% from $5,110 million, and GAAP diluted EPS of $0.86, down 5% from $0.91. Excluding a $129 million charge tied to its Strategic Growth and Productivity Program, Base Business EPS rose 8% to $0.99, and the company updated its full-year 2026 gross margin and Base Business EPS guidance upward while keeping its sales and GAAP EPS guidance.
Net sales rose 4.9% to $5,361 million; organic sales rose 2.4%, and Total Company operating profit fell 6% to $1,016 million.
GAAP gross profit margin rose 140 basis points to 61.5%; Base Business EPS rose 8% to $0.99 from $0.92.
Full-year 2026 guidance: GAAP and Base Business gross profit margin now expected roughly flat (previously down); Base Business EPS growth now expected mid-single-digit (previously low- to mid-single-digit).
Net sales guidance of up 2% to 6% and GAAP EPS guidance were maintained.
AbbVie reported second-quarter 2026 net revenues of $16.99 billion, up 10.2% on a reported basis, and adjusted diluted EPS of $3.65, up from $2.97 a year earlier. It lowered its 2026 adjusted EPS guidance to $13.87-$14.07 from $13.91-$14.11, a $0.04 midpoint cut, mainly because of a $0.14 per share dilutive impact from the proposed Apogee Therapeutics acquisition.
Q2 net revenues were $16.990 billion, up 10.2% reported and 9.5% operational; Skyrizi revenues were $5.505 billion, up 24.4%.
Q2 GAAP diluted EPS was $2.03 versus $0.52 a year earlier; adjusted diluted EPS was $3.65 versus $2.97.
2026 adjusted diluted EPS guidance is now $13.87-$14.07 versus $13.91-$14.11, including a $0.14 dilutive impact from Apogee, partly offset by $0.10 of overperformance.
AbbVie agreed to acquire Apogee Therapeutics, valued at a total equity value of about $10.9 billion, with closing expected in the third quarter of 2026.
Perella Weinberg reported second-quarter 2026 revenue of $156.5 million, up 1% from a year earlier, and GAAP diluted EPS of $0.06 versus $0.04. First-half revenue fell 17% to $305.4 million, and the company recorded $13.7 million of business realignment costs tied to headcount reductions, so the quarter's gains are offset by a weaker six-month picture for shareholders.
Q2 2026 GAAP diluted EPS was $0.06 versus $0.04 a year earlier; adjusted EPS was $0.20 versus $0.09.
First-half 2026 revenue was $305.4 million, down from $367.1 million, driven by fewer large fee event closings.
Business realignment costs were $13.7 million in Q2; the company estimates about $22 million in total through the end of 2026.
Cash was $115.8 million with no debt; the board declared a $0.07 per share quarterly dividend payable September 10, 2026.
Perimeter Solutions reported second-quarter 2026 net sales of $213.8 million, up 31% from a year earlier, but posted a net loss of $181.6 million, or $1.11 per diluted share, versus a $32.2 million loss a year earlier. The filing attributes the larger loss mainly to $266.3 million in founders advisory fees, and adjusted earnings per diluted share fell to $0.35 from $0.39.
Net sales rose 31% to $213.8 million; Specialty Products sales doubled to $84.7 million and Fire Safety sales rose 7% to $129.1 million.
GAAP net loss was $181.6 million, or $1.11 per diluted share, compared with a net loss of $32.2 million, or $0.22 per diluted share, a year earlier; founders advisory fees were $266.3 million.
Adjusted EBITDA rose 16% to $105.6 million; adjusted earnings per diluted share were $0.35 versus $0.39 a year earlier.
On July 30, 2026, the company acquired Monaco Enterprises for $120.0 million in cash, net of cash acquired, which it expects to contribute more than $11 million of annualized Adjusted EBITDA.
Federal Realty Investment Trust reported second quarter 2026 results with total revenue of $335.7 million, up from $311.5 million a year earlier, and diluted earnings per share of $0.97, down from $1.78, mainly because of a lower gain on property sales and the absence of a one-time tax credit in 2025. Core FFO per diluted share rose 6.8% to $1.88, and the company raised its full-year 2026 guidance for earnings and FFO per diluted share, while also raising its quarterly dividend 3% to $1.16 per share.
Q2 2026 diluted EPS was $0.97 versus $1.78 in Q2 2025; gain on sale of real estate was $20.6 million versus $76.5 million
Core FFO per diluted share was $1.88, up from $1.76, a 6.8% increase; Nareit FFO per diluted share was $1.88 versus $1.91
2026 guidance raised: diluted EPS to $4.22 to $4.30 from $3.94 to $4.03; Core FFO per diluted share to $7.48 to $7.56 from $7.46 to $7.55
Quarterly dividend increased to $1.16 per share, payable October 15, 2026, the 59th consecutive annual increase
Dominion Energy reported preliminary second-quarter 2026 results, with operating earnings (non-GAAP) of $712 million ($0.79 per share) up from $649 million ($0.75) a year earlier. GAAP net income fell to $340 million ($0.37 per share) from $760 million ($0.88), with the gap driven largely by non-operating items such as $626 million of nonregulated asset impairments and other charges in the quarter. The company reaffirmed its full-year 2026 operating earnings guidance of $3.45 to $3.69 per share.
Operating revenue was $4,480 million for the quarter, up from $3,810 million in the second quarter of 2025.
GAAP net income was $340 million ($0.37 per share), compared with $760 million ($0.88 per share) a year earlier.
Operating earnings were $712 million ($0.79 per share), compared with $649 million ($0.75 per share).
Full-year 2026 operating earnings guidance of $3.45 to $3.69 per share (midpoint $3.57) was reaffirmed, and the company is holding its earnings call at 11 a.m. ET on July 31, 2026.
Church & Dwight reported second-quarter 2026 net sales of $1,530.0 million, up 1.6% from a year earlier, and diluted EPS of $0.85 versus $0.78. Adjusted EPS was $0.89, above the company's $0.88 outlook but down from $0.94 last year, and the company raised its full-year 2026 sales, adjusted EPS and cash from operations outlook. For shareholders, sales and reported earnings grew while adjusted earnings declined, and the company now expects higher full-year results.
Net sales $1,530.0 million, up 1.6%; organic sales up 5.8%; adjusted EPS $0.89 vs. $0.94 a year earlier
Diluted EPS $0.85 vs. $0.78; adjusted income from operations $287.2 million, down $28.7 million
Full-year 2026 outlook: net sales flat to up 1% (prior down 1.5% to 0.5%); adjusted EPS up 6% to 8% (prior 5% to 8%)
Cash from operations now expected at about $1.175 billion (prior $1.150 billion); MISS MOUTH'S brand acquired in June 2026
AutoNation reported second-quarter 2026 results, with revenue of $6.9 billion, down 1% from a year earlier. GAAP diluted EPS was $5.39, up from $2.26, and adjusted EPS was $5.56, up 2% from $5.46. For shareholders, profit rose while sales and gross profit fell.
Revenue was $6.9 billion, down 1% year over year, and gross profit was $1.2 billion, down 3%.
GAAP diluted EPS was $5.39 versus $2.26 a year ago; adjusted EPS was $5.56 versus $5.46.
Same-store new vehicle retail unit sales fell 5% and used vehicle retail unit sales fell 8%.
The company repurchased $457 million of shares in the first half of 2026.
Eaton reported record second-quarter 2026 sales of $8.5 billion, up 21% from a year earlier, and adjusted earnings per share of $3.15, a second-quarter record. GAAP earnings per share fell to $2.11 from $2.51, mainly due to acquisition-related and amortization charges, and the company raised its full-year adjusted EPS guidance to $13.40 to $13.60. The company also agreed to separate its Mobility business through a Reverse Morris Trust transaction with Dana, expected to close in the first quarter of 2027.
Q2 2026 sales were $8.5 billion, up 21%, including 14% organic growth and 7% from acquisitions.
GAAP diluted EPS was $2.11 versus $2.51 a year earlier; adjusted EPS was $3.15 versus $2.95.
Full-year 2026 adjusted EPS guidance was raised to $13.40 to $13.60; GAAP EPS guidance is $10.36 to $10.56.
Mobility business to be combined with Dana in a deal expected to close in the first quarter of 2027; Eaton shareholders expected to own at least 50.1% of the combined company.
Carter's reported second-quarter fiscal 2026 net sales up 5.2% to $615.5 million, and GAAP operating income of $139.8 million and diluted EPS of $2.87 were boosted by a $132 million recovery of previously paid import duties and interest. The company's full-year outlook projects adjusted diluted EPS to fall by a high single-digit to low double-digit percentage from $3.47, so the quarter's gains do not carry through to the full year.
Net sales were $615.5 million, up 5.2% from $585.3 million; U.S. Retail comparable sales rose 5.1%.
GAAP diluted EPS was $2.87 versus $0.01, including a $127.7 million tariff refund recovery; adjusted diluted EPS was $0.26 versus $0.17.
Fiscal 2026 outlook projects net sales growth of 2% to 3% and adjusted diluted EPS down high single-digit to low double-digit percent from $3.47.
Third-quarter outlook projects adjusted diluted EPS of about $0.85, compared with $0.74 in the third quarter of fiscal 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.